Our competitive edge is created by deep insight into the industries in which we operate and our knowledge of the trends and activities that affect our clients. In our chosen sectors, we regularly publish reviews of the dynamics and strategic initiatives driving M&A activity, private equity investment and debt capital deployment.
For more information on our research output, please contact Keith Pickering on +44 (0) 20 7246 0500 or firstname.lastname@example.org
The latest Pharma Fast 50, our list of the 50 fastest-growing privately owned pharmaceutical companies in the UK in 2017
Adobe Acrobat file - 0.3 mb
Healthcare is maintaining the momentum from 2015 and 2016 with deal volumes across the sector high in 2017. Significant liquidity is driving up valuations as corporates and financial investors compete for the best businesses.
Adobe Acrobat file - 1 mb
Our top 5 deals illustrating the trends that have underpinned 2017 M&A activity in healthcare
Adobe Acrobat file - 0.5 mb
The UK’s decision to leave the EU represents a major opportunity for the country’s dynamic and world-leading pharmaceutical sector – despite warnings that Brexit could prompt pharma companies to quit the UK.
Adobe Acrobat file - 0.2 mb